G Medical Innovations (GMVDW) Stock Price, News & Analysis

Company Overview

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.02 to $6.90
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 5,762 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GMVDW Stock Analysis - Frequently Asked Questions

When did G Medical Innovations' stock split?

G Medical Innovations's stock reverse split on the morning of Sunday, November 20th 2022.The 1-35 reverse split was announced on Sunday, November 20th 2022. The number of shares owned by shareholders was adjusted after the market closes on Sunday, November 20th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Surgical Appliance & Supplies Manufacturing
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:GMVDW
• CIK: 1760764
• Web: gmedinnovations.com
• Phone: 972 8 958 4777
• Fax: N/A
• Employees: 72
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $4.42 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A